Scott A. Campbell, Corporate VP & CRO at CEPHEID (CPHD), sold 157 shares at $37.57 ($6K) on 2016-08-05, disclosed to the SEC on 2016-08-09.
Scheduled sale ($6k) by Corporate VP & CRO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CPHD | SELL | 2016-05-03 | $115K | — | Filing → |